ENDPOINTS

#AAD25 roundup: Data from Amgen, Bristol Myers, J&J, Alumis and more

At this year’s American Academy of Dermatology annual meeting, companies like Amgen, Bristol Myers Squibb and Alumis took the stage to report the latest on their dermatology candidates. Here are the highlights: Amgen, Kyowa Kirin ...

Mar 10, 2025 - 16:39
 0
#AAD25 roundup: Data from Amgen, Bristol Myers, J&J, Alumis and more
At this year’s American Academy of Dermatology annual meeting, companies like Amgen, Bristol Myers Squibb and Alumis took the stage to report the latest on their dermatology candidates. Here are the highlights: Amgen, Kyowa Kirin ...
Read More

Tags:

Previous Article

Meta Details Path to ‘Significantly Reduced Costs’ of Most Critical Component of...

Next Article

Meta Details Path to ‘Significantly Reduced Costs’ of Next-gen AR’s Most Critica...

Related Posts

Novo Nordisk’s rare disease ‘company within a company’ has an open goal in sickle cell

Novo Nordisk’s rare disease ‘company within a company’ ...

Mar 6, 2025  0

In single case, spinal muscular atrophy pill given before birth spared baby of symptoms

In single case, spinal muscular atrophy pill given befo...

Feb 20, 2025  0

BioNTech vets raise about $90M in Series A for bispecific immunology research

BioNTech vets raise about $90M in Series A for bispecif...

Feb 14, 2025  0